References

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 186 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Laboratory Effectiveness: Clinical Laboratory Utilization. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Laboratory Effectiveness: Clinical Laboratory Utilization (online CE course)
References

Baird GS, Rainey PM, Wener M, Chandler W. Reducing routine ionized calcium measurement. Clin Chem. 2009;55(3):533-540.
Guerry SL, Bauer HM, Packel L, et al. Chlamydia screening and management practices of primary care physicians and nurse practitioners in California. J Gen Intern Med. 2005;20(12).
Howanitz PJ, Steindel SJ. Digoxin therapeutic drug monitoring practices. A College of American Pathologists Q-Probes study of 666 institutions and 18,679 toxic levels. Arch Pathol Lab Med. 1993;117(7):684–690.
Improving laboratory test utilization through physician report cards with feedback from leadership: an interview with Kim Riddell, MD. Laboratory Errors and Patient Safety. 2006;2(4).
Levenson D. Which tests should be considered obsolete? Clin Lab News. December 2007:33(12).
Lusky K. Pulling back the reins on superfluous testing. CAP TODAY. September 2010.
McGrath, Maggie. 63% of Americans Don't have Enough Savings to Cover a $500 Emergency. Forbes. January 6, 2016. Available at: https://www.forbes.com/sites/maggiemcgrath/2016/01/06/63-of-americans-dont-have-enough-savings-to-cover-a-500-emergency/#1d55b0534e0d Accessed February 22, 2023.
Moyer AM. Saenger AK, Willrich M, et al. Implementation of clinical decision support rules to reduce repeat measurement of serum ionized calcium, magnesium and NT-proBNP in ICU patients. Clin Chem. June 2016; 62(6): 824-830.
Our skyrocketing health care costs, in one chart. The Washington Post. Taken from OECD Health Data. June 2011.
Qureshi AI, Suri FK, Guterman LR, et al. Ineffective secondary prevention in survivors of cardiovascular events in the US population. Arch Intern Med. 2001;161:1621–1628.
United Health Center for Health Reform & Modernization/Harris Interactive survey of consumers. January 2012.
Valenstein PN, Walsh MK, Meier F, et al. Heparin monitoring and patient safety: a College of American Pathologists Q-Probes study of 3431 patients at 140 institutions. Arch Pathol Lab Med. 2004;128:397–402.